Tag: FDA

AI-generated illustration of a brass balance scale with two empty pans standing beside two unlabeled glass vials with red caps and a navy stethoscope on a walnut desk against a navy wall, representing the weighing of evidence for compounded peptides.

Compounded Peptides May Return in 2026: A Florida Guide

The Washington Post reports that the administration is preparing a temporary measure that would let compounding pharmacies sell some previously restricted peptides, including BPC-157. The plan has not been announced. Where the law stands today, what would not change under Florida law, and six things a Florida physician should do now.

AI-generated illustration of an autonomous robotic phlebotomy device drawing blood from an older patient in an outpatient clinic while a phlebotomist supervises

The FDA Authorized a Robotic Blood Draw Device. This Is the Iron Triangle Bending.

The FDA authorized Vitestro's Aletta, the first autonomous robotic blood draw device. One trained supervisor, three machines, 94.5% first-stick success. That combination is what bending Kissick's iron triangle actually looks like.

AI-generated illustration: FDM illustration - checklist clipboard with reform icons

Makary’s Year 2 Wishlist: A New FDA Pathway, Lower User Fees, and What Florida Physicians Should Be Asking For

Marty Makary's second-anniversary wishlist for Congress includes a new Plausible Mechanism Pathway, lower PDUFA fees, and a permanent rare-disease voucher program. Florida physicians need to be in the room — here's what to do now.